Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Respiratory function in progressive systemic sclerosis.

Literature DB >> 14019386

Respiratory function in progressive systemic sclerosis.

M CATTERALL, N R ROWELL.

Abstract

Entities: Disease

Keywords: SCLERODERMA

Mesh：

Year: 1963 PMID： 14019386 PMCID： PMC1018732 DOI： 10.1136/thx.18.1.10

Source DB: PubMed Journal: Thorax ISSN： 0040-6376 Impact factor: 9.139

× No keyword cloud information.

10 in total

1. Scleroderma of the lungs.

Authors: R D MILLER; W S FOWLER; F H HELMHOLZ
Journal: Proc Staff Meet Mayo Clin Date: 1959-02-04

2. Variability of tissue-localizing properties of serum from patients with different disease states.

Authors: R H FENNELL; G P RODNAN; J J VAZQUEZ
Journal: Lab Invest Date: 1962-01 Impact factor: 5.662

3. Pulmonary fibrosis in scleroderma: report of a case with pulmonary function studies to evaluate corticosteroid and relaxin therapy.

Authors: R E TRANQUADA; D H SIMMONS; J H MILLER
Journal: Arch Intern Med Date: 1960-04

4. Clinical and roentgenologic signs of collagen diseases involving the thorax.

Authors: C M NICE; A N MENON; L G RIGLER
Journal: Dis Chest Date: 1959-06

5. Clinical determination of the diffusion capacity of the lungs; comparison of methods in normal subjects and patients with alveolar-capillary block syndrome.

Authors: J B CADIGAN; D W CUGELL; E A GAENSLER; A MARKS
Journal: Am J Med Date: 1957-01 Impact factor: 4.965

6. A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide.

Authors: W S BLAKEMORE; R E FORSTER; J W MORTON; C M OGILVIE
Journal: J Clin Invest Date: 1957-01 Impact factor: 14.808

7. Scleroderma; pulmonary and skin studies before and after treatment with cortisone.

Authors: A SALOMON; B APPEL; E F DOUGHERTY; J A HERSCHFUS; M S SEGAL
Journal: AMA Arch Intern Med Date: 1955-01

8. Lupus erythematosus cells in systemic sclerosis.

Authors: N R ROWELL
Journal: Ann Rheum Dis Date: 1962-03 Impact factor: 19.103

9. Effects of cortisone and ACTH in cases of chronic pulmonary disease with impairment of alveolar-capillary diffusion.

Authors: J R WEST; J H McCLEMENT; D CARROLL; H A BLISS; M KUSCHNER; D W RICHARDS; A COURNAND
Journal: Am J Med Date: 1951-02 Impact factor: 4.965

10. The pulmonary manifestations of scleroderma; an anatomic-physiological correlation.

Authors: D M SPAIN; A G THOMAS
Journal: Ann Intern Med Date: 1950-01 Impact factor: 25.391

10 in total

8 in total

8. Diffusing capacities and ventilation: perfusion ratios in patients with the clinical syndrome of alveolar capillary block.

Authors: H Arndt; T K King; W A Briscoe
Journal: J Clin Invest Date: 1970-02 Impact factor: 14.808

8 in total

Respiratory function in progressive systemic sclerosis.

1. Scleroderma of the lungs.

2. Variability of tissue-localizing properties of serum from patients with different disease states.

3. Pulmonary fibrosis in scleroderma: report of a case with pulmonary function studies to evaluate corticosteroid and relaxin therapy.

4. Clinical and roentgenologic signs of collagen diseases involving the thorax.

5. Clinical determination of the diffusion capacity of the lungs; comparison of methods in normal subjects and patients with alveolar-capillary block syndrome.

6. A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide.

7. Scleroderma; pulmonary and skin studies before and after treatment with cortisone.

8. Lupus erythematosus cells in systemic sclerosis.

9. Effects of cortisone and ACTH in cases of chronic pulmonary disease with impairment of alveolar-capillary diffusion.

10. The pulmonary manifestations of scleroderma; an anatomic-physiological correlation.

1. PULMONARY FUNCTION IN SCLERODERMA.

2. PULSE DEXAMETHASONE THERAPY IN SYSTEMIC SCLEROSIS.

3. Association between immunosuppressive therapy and course of mild interstitial lung disease in systemic sclerosis.

4. Lung function in rheumatoid arthritis. A clinic survey.

5. Lung function and the response to exercise in systemic sclerosis.

6. Serial pulmonary function tests in progressive systemic sclerosis.

7. Lung function abnormalities in different connective tissue diseases.

8. Diffusing capacities and ventilation: perfusion ratios in patients with the clinical syndrome of alveolar capillary block.